Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Dual-Ligand Synergistic Construction of Double-Walled Cage Zn-MOFs: Methyl Modification Regulates Pore Size and Selective C2H2/CO2 Separation Performance.

Created on 09 Aug 2026

Authors

Hongke Dong, Xinhui Chen, Haibo Wang, Zerui Wang, Shubin Wang, Shaohua Cheng, Jie Song, Mingliang Chen, Xiaoqing Lu, Fangna Dai

Published in

ACS applied materials & interfaces. Aug 10, 2026. Epub Aug 10, 2026.

Abstract

Due to the extremely similar molecular sizes and melting and boiling points of acetylene (C2H2) and carbon dioxide (CO2), their efficient separation and purification have long been significant challenges in the field of industrial purification. Based on the ligand construction strategy, this study selected 2,4,6-tris(4-carboxyphenyl)-1,3,5-triazine as the main ligand and coordinated it with 3-methyl-1H-1,2,4-triazole and 3,5-dimethyl-1H-1,2,4-triazole, respectively, to assemble metal-organic frameworks (MOFs), successfully preparing two double-walled MOF crystal materials: Zn-TATB-fmtrz and Zn-TATB-dmtrz. Among them, Zn-TATB-fmtrz has a larger pore size (11.64 × 6.63 Å), while the pore size of the comparative material Zn-TATB-dmtrz is only 4.94 × 4.30 Å; in addition, the specific surface area of Zn-TATB-fmtrz (1403.4 m2/g) is also significantly higher than that of Zn-TATB-dmtrz (826.4 m2/g). Benefiting from the above structural advantages, both MOF materials can achieve efficient separation of C2H2/CO2. Systematic adsorption tests indicate that under conditions of 298 K and 1 bar, the maximum acetylene adsorption capacity of Zn-TATB-fmtrz reaches 58.6 cm3/g, much higher than the 37.5 cm3/g of Zn-TATB-dmtrz; moreover, the adsorption selectivity of Zn-TATB-fmtrz for C2H2/CO2 is 3.0, slightly better than 2.9 for Zn-TATB-dmtrz. Dynamic breakthrough experiments based on real binary mixtures further visually confirm that Zn-TATB-fmtrz shows potential for practical C2H2/CO2 separation.

PMID:
42571654
Bibliographic data and abstract were imported from PubMed on 09 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement